BRADLEY MERRILL THOMPSON is a Member of the Firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues.
Mr. Thompson serves as Chairman of the Board of EBG Advisors, Inc. Affiliated with the law firm, EBG Advisors is a Washington, D.C., based consultancy that takes a multidisciplinary approach to helping health care and life sciences companies navigate the many obstacles that they face. EBG Advisors is a network of international attorneys, regulatory affairs professionals, reimbursement experts, engineers, clinicians, quality systems advisors, and other professionals who specialize in providing coordinated guidance and solutions across various segments of the health care industry. In his role with EBG Advisors, Mr. Thompson leads multidisciplinary teams delivering those integrated services.
Mr. Thompson regularly defends companies receiving FDA warning letters, on a wide gamut of subjects including good manufacturing practice compliance and off label promotion. He frequently counsels companies on premarket clearance and approval strategies and on marketing strategies. When medical device companies become concerned that perhaps their employees have not followed FDA requirements, they often engage Mr. Thompson to investigate. With a special focus on drug delivery companies, Mr. Thompson also advises such companies on the unique aspects of combination product development and manufacturing.